-Reuters   PERLE: As a shiny red harvester bounces across the black earth into the first row of sugar cane, excited schoolchildren run after it and several dozen men stand gaping in the wake of its swift progress. It's the first time that Perle, a village on the banks of the Krishna river in Maharashtra state, has seen a machine used for cutting the tough cane. "This machine will harvest my entire field today,"...

The Prime Minister's Economic Advisory Council has suggested a complex combination of three pricing models to fix retail prices of 348 essential drugs to balance industry's concerns and public health. The proposal, however, has drawn the ire of drug makers who say it is a watered down version of the health ministry's proposals. The council has proposed that for medicines facing "insufficient competition" or a monopoly-like situation, the retail price should...

 Madhya Pradesh cancelled licences of seven 'gutkha' companies and banned its manufacture and sale in the state from April 1. MP is the first state in the country to ban tobacco, magnesium carbonate and nicotine-based 'gutkha' following provisions of the Food Safety and Standards (Prohibition and Restriction on Sales) Regulation 2011.  Health minister and government spokesman Narottam Mishra said gutkha manufacturing licences in the state will not be renewed. "Gutkha makers...

The reduced allocation to the UPA government’s flagship rural programme NREGA could see revenue growth in the FMCG sector falter. Consumer staples firms have been relying on rural demand growth to bolster their top line but the reduced allocation to the Mahatma Gandhi National Rural Employment Guarantee Scheme (NREGA) for the financial year 2012-13 could see growth in FMCG sales in rural areas being crimped feel industry experts. Finance minister Pranab...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...